Alnylam Pharmaceuticals, Inc. earnings per share and revenue

ALNY earnings per share for the last quarter are -0.87 USD whereas the estimation was -0.92 USD which accounts for 5.09% surprise. Company revenue for the same period amounts to 500.92 M USD despite the estimated figure of 532.91 M USD. Estimated earnings per share for the next quarter are -0.59 USD, and revenue is expected to reach 579.59 M USD. Also watch annual changes over time to get a bigger picture of ALNY earnings per share and revenue dynamics.